Death of tumor cells. Photodynamic reaction in apoptosis induction in cancer cells;Śmierć komórek nowotworowych. Udział reakcji fotodynamicznej w indukcji apoptozy w komórkach nowotworowych

Polski Merkuriusz Lekarski

Volumn 30, Issue 175, 2011, Pages 45-48

  ChwiŁkowska, Agnieszka ^a   Kulbacka, Julita ^a   Saczko, Jolanta ^a,b  

^a UNIVERSITY OF WROC AW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Caspases; P53; Photodynamic therapy

Indexed keywords

CASPASE; PROTEIN P53;

ANIMAL; CELL DEATH; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHOTOCHEMOTHERAPY; REVIEW;

ANIMALS; CASPASES; CELL DEATH; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952177798     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Adams J.M.: Ways of dying: multiple pathways to apoptosis. Gen. Dev., 2003, 17, 2481-2495.
2. Carthy CM., Granville D.J., Jiang H. I wsp.: Early release of mitochondrial cytochrome c and expression of mitochondrial etitope 7A6 with a porphyrin-derived photosensitizer. Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial evens but still depress caspase activity. Lab. Invest., 1999, 79, 953-965.
3. Di Stefano A., Ettore A., Sbrana S. I wsp.: Purpurin-18 in combination with light leads to apoptosis or necrosis in HL60 leukemia cells. Photochem. Photobiol., 2001, 73(3), 290-296.
4. Gough M.J., Melcher A.A., Achmed A. i wsp.: Macrophages orchestrate the immune response to tumor cell death. Cancer Res., 2001, 61, 7240-7247.
5. Granville DJ., McManus B.M., Hunt D.W.C.: Photodynamic therapy: sheding light on biochemical pathways regulating porphyrin - mediated cell death. Histol. Histopathol., 2001, 16, 309-317.
6. Gra̧dzka I.: Apoptoza: decyzja należy do mitochondrium. Post. Biochem., 2000, 46(1), 2-16.
7. He J., Agrawal M.L., Larkin H.E. i wsp.: The induction of partial resistance to photodynamic therapy by the protooncogene Bcl-2. Photochem. Photobiol., 1996, 64, 845-852.
8. Higuchi Y.: Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative atress. Biochem. Pharmacol., 2003, 66, 1527-1535.
9. Ho P., Hawkins C.J.: Mammalian initiator apoptotic caspases. FEBS J., 2005, 272, 5436-5453.
10. Horn H.F., Vousden K.H.: Cencer. Guarding the guardian? Nature., 2004 427 (6970), 110-111.
11. Kessel D., Reinere J. J.: Initiation of apoptosis and autophagy by the Bcl2 antagonist Ha14-1. Cancer Letters., 2007, 8, 294-299.
12. Kessel D., Vicente G.H., Reinere J.J.: Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg. Med., 2006, 38, 482-488.
13. Kiliańska Z.M., Miśkiewicz A.: Kaspazy krȩ gowców - rola w przebiegu apoptozy. Post. Biol. Kom., 2003, 30 (1), 129-151.
14. Korzeniowska-Dyl I.: Kaspazy- struktura i funkcje. Pol. Merk. Lek., 2007, 138, 403-407
15. LeBlanc A.C.: Natural cellular inhibitors of caspases. Prog. Neuropsychopharmacol. Biol. Psychiatry., 2003, 27, 215-229.
16. Li R., Bounds D.J., Granville D. I wsp.: Rapid induction of apoptosis in human keratinocytes with the photosensitizer QLT 0074 via a direct mitochondrial action. Apoptosis, 2003, 8(3), 269-275. (Pubitemid 36749612)
17. Luo Y., Kessel D.: Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine. Photochem. Photobiol., 1997, 66 (4), 479-483.
18. Maaser K., Sutter A.P., Krahn A.: Cell cycle - related signaling pathways modulated by peripheral benzodiazepine receptor ligands in colorectal cancer cells. Biochem. Biophysic. Res. Commun., 2004, 324, 878-886.
19. Okada H., Mak T.W.: Pathways of apoptotic and non-apoptotic death in tumor cells, Nat. Rev. Cancer., 2004, 4, 592-603.
20. Oleinick N.L., Morris R.L., Belichenko I.: The role of apoptosis in response of photodynamic therapy: what, why, and how. Photochem. Photobiol. Sci., 2002, 1, 1-21.
21. Ricci M.S., Zong W.X.: Chemioterapeutic appraches for targeting cell death pathways. Oncologist., 2006, 11, 303-313.
22. Ryan K.M., Phillips A.C., Vousden K.H.: Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol., 2001, 13, 332-337.
23. Sorenson CM.: Bcl-2 family members and disease. Biochim. Biophys. Acta., 2004, 1644, 169-177.
24. Stȩpień A., Izdebska M., Grzanka A.: Rodzaje śmierci komórki. Postȩpy Hig. i Med. Dośw., 2007, 61, 420-428.
25. Sutcliffe J.E., Brehm A.: Of flies and man: p53, a tumor suppressor. FEBS Letters, 2004, 567, 86-91.
26. Vames M.E., Chiu S.M., Xue L.Y. i wsp.: Photodynamic therapy - induced apoptosis in lymphoma cells: translocation of cytochrome c cause inhibition of respiration as well as caspase activation. Biochem. Biophys. Res. Commun., 1999, 255, 673?679.
27. Verma A., Facchina S.L., Hirsch D.J. i wsp.: Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target. Mol. Med., 1998, 4, 40-45.
28. Xue L.Y., Chiu S.M., Oleinick N.L.: Photodynamic Therapy - Induced Death of MCF-7 Human Breast Cancer Cells: A Role for Caspase-3 in the Late Steps of Apoptosis but Not for the Critical Lethal Event. Exp. Cell Res., 2001, 263, 145?155.
29. Zhang W.G., Ma L.P., Wang S.W. I wsp.: Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy. Photochem. Photobiol., 1999, 96, 582-586.